Trigeminal nerve transposition by sling-pulling technique in combination with macrovascular transposition for giant basilar artery–induced trigeminal neuralgia via a combined transpetrosal approach - Scorecard - MDSpire

Trigeminal nerve transposition by sling-pulling technique in combination with macrovascular transposition for giant basilar artery–induced trigeminal neuralgia via a combined transpetrosal approach

  • By

  • Duangprasert, Gahn

  • Nimmannitya, Pree

  • Yindeedej, Vich

  • Noiphithak, Raywat

  • March 4, 2026

  • 0 min

Share

Clinical Scorecard: Sling-Pulling Technique for Trigeminal Nerve Transposition Combined with Macrovascular Transposition in Treating Giant Basilar Artery-Induced Trigeminal Neuralgia via a Transpetrosal Approach

At a Glance

CategoryDetail
ConditionTrigeminal neuralgia caused by giant dolichoectatic basilar artery (DBA) compression
Key MechanismsMechanical compression of trigeminal nerve root exit zone (TGN-REZ) by a gigantic DBA
Target PopulationPatients with refractory trigeminal neuralgia due to giant DBA, especially those intolerant or allergic to carbamazepine
Care SettingNeurosurgical operative setting utilizing combined transpetrosal approach (CTPA)

Key Highlights

  • Giant DBA-induced trigeminal neuralgia is rare and challenging with high failure and recurrence rates after conventional microvascular decompression (MVD).
  • The sling-pulling technique for trigeminal nerve transposition combined with macrovascular transposition (MaVT) via CTPA provides durable decompression and favorable outcomes.
  • CTPA allows optimal exposure, enlargement of posterior fossa space, and safe manipulation of the giant DBA and trigeminal nerve.

Guideline-Based Recommendations

Diagnosis

  • Use brain imaging to identify giant DBA compressing the trigeminal nerve root exit zone.
  • Assess clinical presentation of typical trigeminal neuralgia symptoms refractory to medication.

Management

  • First-line treatment is carbamazepine; consider surgery if refractory or allergic.
  • Surgical options include microvascular decompression (MVD), microvascular transposition (MVT), and macrovascular transposition (MaVT).
  • For giant DBA-induced TGN, perform combined trigeminal nerve transposition using sling-pulling technique and MaVT via combined transpetrosal approach (CTPA).

Monitoring & Follow-up

  • Postoperative monitoring for facial hypoesthesia and facial palsy; expect possible transient facial palsy resolving within months.
  • Long-term follow-up to assess pain relief and recurrence.

Risks

  • Potential facial palsy (House-Brackmann grade 3) and hypoesthesia postoperatively.
  • Technical challenges and higher complication rates with MVT compared to conventional MVD.
  • Risk of vascular kinking and perforator injury mitigated by thorough arachnoid dissection and careful transposition.

Patient & Prescribing Data

Patients with typical trigeminal neuralgia refractory to carbamazepine or with carbamazepine allergy, caused by giant DBA compression

Carbamazepine is first-line but may be ineffective or intolerable; surgical intervention with sling-pulling trigeminal nerve transposition and MaVT offers durable pain relief and symptom resolution.

Clinical Best Practices

  • Perform thorough arachnoid dissection to free neurovascular structures and preserve function during surgery.
  • Open Meckel’s cave to mobilize the trigeminal nerve for effective transposition.
  • Anchor the trigeminal nerve permanently using a non-absorbable biological patch fixed to temporal dura via sling-pulling technique.
  • Use Teflon felt soaked in fibrin glue to support and reposition the giant DBA safely.
  • Employ combined transpetrosal approach (CTPA) for optimal surgical exposure and enlargement of posterior fossa space.
  • Monitor and manage postoperative facial nerve function; expect possible transient palsy with potential full recovery.

References

Original Source(s)

Related Content